Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AVADEL PHARMACEUTICALS PLC Director's Dealing 2019

Nov 14, 2019

31920_dirs_2019-11-14_aa7f6ccb-7e44-40e9-860a-9809b555a1a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2019-11-05

Reporting Person: Vaughn Jason (Sr. VP, Technical Operations)

More from AVADEL PHARMACEUTICALS PLC

Regulatory Filings 2026
Feb 23
Director's Dealing 2026
Feb 18
Director's Dealing 2026
Feb 12
Director's Dealing 2026
Feb 12
Director's Dealing 2026
Feb 12
Director's Dealing 2026
Feb 12
Delisting Announcement 2026
Feb 12
Director's Dealing 2026
Feb 12
Director's Dealing 2026
Feb 12
Director's Dealing 2026
Feb 12
View all filings →